IL-2 promoted Treg cell development via AP-1 transcription factor JunB, and injection of IL-2–anti-IL-2 antibody complex in JunBfl/fl Cd4-Cre mice expanded Treg cells and alleviated DSS-induced colitis (Katagiri et al., 2019). Here, CD4 is linked to colitis.